[4-amino-2-(4-chlorophenylamino)-thiazol-5-yl]-phenylmethanone | 196877-94-8

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: [4-amino-2-(4-chlorophenylamino)-thiazol-5-yl]-phenylmethanone
• 英文别名: [4-amino-2-(4-chlorophenylamino)thiazol-5-yl]phenylmethanone；4-amino-5-benzoyl-2-(p-chlorophenylamino)thiazole；[4-amino-2-(4-chloro-phenylamino)-thiazol-5-yl]-phenyl-methanone；[4-amino-2-(4-chloro-phenylamino)thiazol-5-yl]phenylmethanone；[4-Amino-2-(4-chloroanilino)-1,3-thiazol-5-yl](phenyl)methanone；[4-amino-2-(4-chloroanilino)-1,3-thiazol-5-yl]-phenylmethanone
• CAS: 196877-94-8
• 化学式: C₁₆H₁₂ClN₃OS
• 分子量: 329.81
• InChiKey: LFUAJHRRAYJVBI-UHFFFAOYSA-N

物化性质

• 熔点：
  200-201 °C
• 沸点：
  555.0±60.0 °C(Predicted)
• 密度：
  1.430±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  5.3
• 重原子数：
  22
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  96.2
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  4-氯异硫氰酸苯酯 在 三乙胺 、 sodium hydroxide 作用下， 以 二甲基亚砜 为溶剂， 反应 1.0h， 生成 [4-amino-2-(4-chlorophenylamino)-thiazol-5-yl]-phenylmethanone
  参考文献：
  名称：

  One-pot sequential multicomponent route to 2,4-diaminothiazoles—a facile approach to bioactive agents for cancer therapeutics

  摘要：

  A facile one-pot sequential three-component route to 2,4-diaminothiazoles is reported. The new approach employs the mildest reaction conditions and commercially available reagents to generate diverse 2-alkyl/arylamino-4-amino-5-aroyl/heteroylthiazoles in short reaction times, good yield, and purity. (C) 2012 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tetlet.2012.05.010

文献信息

• Use of 2,4-diaminothiazole derivatives
  申请人：——

  公开号：US20010039275A1

  公开（公告）日：2001-11-08

  2,4-Diaminothiazole derivatives which inhibit GSK-3 (glycogen synthase kinase-3) and which are useful for the treatment and/or prevention disorders and diseases wherein an inhibition of GSK-3 is beneficial, especially especially Alzheimer's disease, bipolar disorder, IGT (impaired glucose tolerance), Type 1 diabetes, Type 2 diabetes and obesity.

  抑制GSK-3（糖原合成激酶-3）的2,4-二氨基噻唑衍生物，对治疗和/或预防GSK-3抑制有益的疾病和疾病特别有效，尤其是阿尔茨海默病、双相情感障碍、糖耐量受损（IGT）、1型糖尿病、2型糖尿病和肥胖症。
• [EN] DIAMINOTHIAZOLE COMPOUNDS, COMPOSITIONS AND METHODS OF USE<br/>[FR] COMPOSÉS DE DIAMINOTHIAZOLE, COMPOSITIONS ET PROCÉDÉS D'UTILISATION ASSOCIÉS
  申请人：APOGEE BIOTECHNOLOGY CORP

  公开号：WO2018089902A1

  公开（公告）日：2018-05-17

  The disclosure relates to diaminothiazole derivatives of formula (I) where the variables are as defined herein, pharmaceutical compositions containing such compounds, and methods for the use of such compounds and compositions for the treatment of hyperproliferative, inflammatory or neurologic diseases and disorders.

  本公开涉及式(I)的二氨基噻唑衍生物，其中变量如本文所定义，以及含有这种化合物的药物组合物，以及使用这种化合物和组合物治疗过度增生性、炎症性或神经系统疾病和紊乱的方法。
• An efficient protocol for solid phase aminothiazole synthesis
  作者：Kumaran G. Sreejalekshmi、Satyabhama K.C. Devi、Kallikat N. Rajasekharan

  DOI：10.1016/j.tetlet.2006.06.169

  日期：2006.8

  An efficient synthesis of 2,4-diamino-5-ketothiazoles under solid phase conditions has been achieved by the reaction of polymer supported amidinothioureas with α-haloketones. This novel synthetic approach involving traceless cleavage from the support is suited for automation, and allows solid phase combinatorial synthesis of 2,4-diamino-5-ketothiazoles in good yields and purities.

  在固相条件下，通过聚合物负载的mid基硫脲与α-卤代酮的反应已实现了2,4-二氨基-5-酮噻唑的有效合成。这种涉及从载体上无痕裂解的新颖合成方法适用于自动化，并允许以良好的收率和纯度进行固相组合合成2,4-二氨基-5-酮噻唑。
• [EN] 2,4-DIAMINOTHIAZOLE DERIVATIVES AND THEIR USE AS GLYCOGEN SYNTHASE KINASE-3 (GSK-3) INHIBITORS<br/>[FR] DERIVES DE 2,4-DIAMINOTHIAZOLE
  申请人：NOVO NORDISK AS

  公开号：WO2001056567A1

  公开（公告）日：2001-08-09

  2,4-Diaminothiazole derivatives which inhibit GSK-3 (glycogen synthase kinase-3) and which are useful for the treatment and/or prevention disorders and diseases wherein an inhibition of GSK-3 is beneficial, especially especially Alzheimer's disease, bipolar disorder, IGT (impaired glucose tolerance), Type 1 diabetes, Type 2 diabetes and obesity.

  2,4-二氨基噻唑衍生物抑制GSK-3（糖原合成酶激酶-3），对于治疗和/或预防抑制GSK-3有益的疾病和疾病特别是阿尔茨海默病、双相情感障碍、IGT（糖耐量受损）、1型糖尿病、2型糖尿病和肥胖症具有用处。
• PDE4B INHIBITORS AND USES THEREFOR
  申请人：Ibrahim Prabha N.

  公开号：US20090286793A1

  公开（公告）日：2009-11-19

  Compounds active on phosphodiesterase PDE4B are provided. Also provided herewith are compositions useful for treatment of PDE4B-mediated diseases or conditions, and methods for the use thereof.

  本发明提供了对磷酸二酯酶PDE4B活性作用的化合物。同时还提供了用于治疗PDE4B介导的疾病或病状的组合物以及其使用方法。